Prof. Yanan Lu | Anesthesia – Vice Chief Physician at Sun Yat-sen Memorial Hospital of Sun Yat-sen University, China
Dr. Lu Yanan is a distinguished clinical anesthesia specialist and academic researcher with a robust career dedicated to improving perioperative care and advancing cancer-related anesthesia research. Her progressive trajectory from clinical residency to Deputy Chief Physician and Research Secretary at Sun Yat-sen Memorial Hospital illustrates her unwavering commitment to medical excellence and scientific inquiry. Over nearly two decades, Dr. Lu has contributed significantly to the understanding of anesthesia’s effects on cancer prognosis, tumor biology, and postoperative outcomes. Her extensive academic portfolio and growing international collaborations position her as a future leader in her discipline, bridging clinical practice with impactful research.
Profile Verified
Scopus
🎓 Education
Dr. Lu’s academic foundation is deeply rooted in the prestigious Sun Yat-sen University system. She earned her Bachelor’s degree in Clinical Anesthesia in 2005, followed by a Master’s degree under the mentorship of Professor Cao Minghui in 2013 at Sun Yat-sen Memorial Hospital. These academic credentials laid the groundwork for her translational research interests. Currently pursuing a PhD in Clinical Anesthesia at the same institution, Dr. Lu continues to build on her academic credentials while actively contributing to high-level research projects that integrate advanced anesthetic techniques and oncology-focused investigations.
🏥 Experience
Dr. Lu has cultivated a well-rounded clinical and research career within the same hospital system, reflecting both loyalty and growth. From 2005 to 2013, she served as a resident physician in the Department of Anesthesia, where she developed her core clinical skills. Promoted to attending physician in 2013, she deepened her specialization while mentoring junior staff. A pivotal moment came during her tenure as a visiting scholar at the University of Virginia (2019–2020), where she expanded her global perspective and scientific rigor. Since 2020, she has also served as Research Secretary, reflecting her leadership in departmental innovation. In May 2023, she ascended to the role of Deputy Chief Physician, a recognition of her clinical acumen and research leadership.
🔬 Research Interest
Dr. Lu’s research interests focus on the interface between anesthesia and oncology. She explores how anesthesia protocols influence tumor behavior, patient immunity, and long-term survival, particularly in breast and pancreatic cancer cases. A secondary but emerging interest involves tumor microenvironment dynamics, such as perineural invasion and tumor-associated Schwann cells, as therapeutic targets. Her current studies delve into molecular pathways and translational interventions, including RNA modifications and gene signatures that forecast prognosis. Dr. Lu is especially passionate about integrating pain management with oncologic safety, a niche yet critical area in perioperative medicine.
🏅 Awards
While formal award records were not listed, Dr. Lu’s rapid ascent to Deputy Chief Physician, her invitation to serve as a visiting scholar in the U.S., and her role as corresponding author in several high-impact journals suggest peer recognition of her work. These milestones, paired with her selection for international collaboration and departmental leadership, exemplify her rising status in the research and clinical community. She is an ideal candidate for formal recognition such as the Best Researcher Award.
📚 Publications
-
✨ “Quantitative definitions of pain, CA19-9, and tumor size as high-risk features of resectable pancreatic cancer”, published in Gland Surgery (2021) – cited by multiple oncology specialists for refining prognostic indicators.
-
🧠 “Can anesthetic effects and pain treatment influence the long-term prognosis of early-stage breast cancer?”, in Annals of Translational Medicine (2021) – opened new avenues in cancer anesthesiology.
-
🤢 “Risk factor analysis of postoperative nausea and vomiting in breast cancer patients under general anesthesia”, in Journal of Sun Yat-sen University (Medical Sciences) (2021) – frequently referenced in clinical guidelines.
-
🧒 “Clinical observation of intravenous lidocaine on agitation in pediatric laparoscopic hernia repair”, (2021) – bridges pediatric anesthesia and postoperative care.
-
🫁 “The use of bronchial blockers in patients with aberrant tracheobronchial anatomy”, in Annals of Translational Medicine (2021) – addresses complex pulmonary interventions.
-
🧬 “Seven-gene signature on tumor microenvironment for predicting prognosis of pancreatic cancer”, in Gland Surgery (2021) – cited 50+ times.
-
🔁 “Tumor-associated Schwann cells as a new therapeutic target in non-neurological cancers”, in Cancer Letters (2025) – groundbreaking study that expands cancer treatment horizons.
✅ Conclusion
Dr. Lu Yanan emerges as a highly qualified nominee for the Best Researcher Award, distinguished by her clinical excellence, leadership, and research innovation. Her ability to translate complex biological mechanisms into patient-centered interventions sets her apart in the field of clinical anesthesia. As she continues her PhD and leads advanced research into cancer-anesthesia interactions and tumor microenvironments, her work promises to impact both academic knowledge and patient care standards. Recognizing her achievements now would not only honor past excellence but also encourage future breakthroughs in anesthesiology and oncology.